Abstract
Whipple’s disease (WD) is a very rare chronic systemic condition characterised by a Th2/T regulatory (Treg) dysregulated immune response versus Tropheryma whipplei, a bacterium widely diffuse in the environment. To investigate whether this Th2/Treg polarised response has a genetic background, we investigated the Th1, Th2, Th17 and Treg cytokine genetic profile of 133 patients with WD. Thanks to the European Consortium on WD (QLG1-CT-2002-01049), the polymorphism of 13 cytokine genes was analysed in 111 German and 22 Italian patients using the polymerase chain reaction with sequence-specific primers (PCR-SSP) technique. The frequencies of the genotypes, haplotypes and functional phenotypes were compared with those obtained in 201 German and 140 Italian controls. Clinical heterogeneity was also considered. Functionally, WD patients may be considered as low producers of TGF-β1, having an increased frequency of the genotype TGF-β1+869C/C,+915C/C [12.3 % vs. 3.81 %, odds ratio (OR) = 4.131, p = 0.0002] and high secretors of IL-4, carrying the genotype IL-4-590T/T (5.34 % vs. 1.17 %, OR = 5.09, p = 0.0096). No significant association was found between cytokine polymorphism and clinical variability. Analogously to the recent cellular findings of a Th2/Treg polarised response, we showed that the cytokine genetic profile of WD patients is skewed toward a Th2 and Treg response. This was similar in both German and Italian populations. However, the significant deviations versus the controls are poorer than that expected on the basis of these recent cellular findings.
Similar content being viewed by others
References
Fenollar F, Puéchal X, Raoult D (2007) Whipple’s disease. N Engl J Med 356:55–66
Moos V, Schneider T (2011) Changing paradigms in Whipple’s disease and infection with Tropheryma whipplei. Eur J Clin Microbiol Infect Dis 30:1151–1158
Maiwald M, Schuhmacher F, Ditton H-J, von Herbay A (1998) Environmental occurrence of the Whipple’s disease bacterium (Tropheryma whippelii). Appl Environ Microbiol 64:760–762
Zinkernagel AS, Gmür R, Fenner L, Schaffner A, Schoedon G, Schneemann M (2003) Marginal and subgingival plaque—a natural habitat of Tropheryma whipplei? Infection 31:86–91
Schöniger-Hekele M, Petermann D, Weber B, Müller C (2007) Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Appl Environ Microbiol 73:2033–2035
Fenollar F, Trani M, Davoust B, Salle B, Birg ML, Rolain JM, Raoult D (2008) Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates. J Infect Dis 197:880–887
Li W, Fenollar F, Rolain J-M, Fournier P-E, Feurle GE, Müller C, Moos V, Marth T, Altwegg M, Calligaris-Maibach RC, Schneider T, Biagi F, La Scola B, Raoult D (2008) Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology 154:521–527
Fenollar F, Mediannikov O, Socolovschi C, Bassene H, Diatta G, Richet H, Tall A, Sokhna C, Trape JF, Raoult D (2010) Tropheryma whipplei bacteremia during fever in rural West Africa. Clin Infect Dis 51:515–521
Raoult D, Fenollar F, Rolain JM, Minodier P, Bosdure E, Li W, Garnier JM, Richet H (2010) Tropheryma whipplei in children with gastroenteritis. Emerg Infect Dis 16:776–782
Martinetti M, Biagi F, Badulli C, Feurle GE, Müller C, Moos V, Schneider T, Marth T, Marchese A, Trotta L, Sachetto S, Pasi A, De Silvestri A, Salvaneschi L, Corazza GR (2009) The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease. Gastroenterology 136:2289–2294
Ponz de Leon M, Borghi A, Ferrara F, Contri M, Roncucci L (2006) Whipple’s disease in a father–son pair. Intern Emerg Med 1:254–256
Dykman DD, Cuccherini BA, Fuss IJ, Blum LW, Woodward JE, Strober W (1999) Whipple’s disease in a father–daughter pair. Dig Dis Sci 44:2542–2544
Gross JB, Wollaeger EE, Sauer WG, Huizenga KA, Dahlin DC, Power MH (1959) Whipple’s disease; report of four cases, including two in brothers, with observations on pathologic physiology, diagnosis, and treatment. Gastroenterology 36:65–93
Desnues B, Ihrig M, Raoult D, Mege JL (2006) Whipple’s disease: a macrophage disease. Clin Vaccine Immunol 13:170–178
Moos V, Schmidt C, Geelhaar A, Kunkel D, Allers K, Schinnerling K, Loddenkemper C, Fenollar F, Moter A, Raoult D, Ignatius R, Schneider T (2010) Impaired immune functions of monocytes and macrophages in Whipple’s disease. Gastroenterology 138:210–220
Benoit M, Desnues B, Mege JL (2008) Macrophage polarization in bacterial infections. J Immunol 181:3733–3739
Desnues B, Lepidi H, Raoult D, Mege JL (2005) Whipple disease: intestinal infiltrating cells exhibit a transcriptional pattern of M2/alternatively activated macrophages. J Infect Dis 192:1642–1646
Marth T, Neurath M, Cuccherini BA, Strober W (1997) Defects of monocyte interleukin 12 production and humoral immunity in Whipple’s disease. Gastroenterology 113:442–448
Marth T, Kleen N, Stallmach A, Ring S, Aziz S, Schmidt C, Strober W, Zeitz M, Schneider T (2002) Dysregulated peripheral and mucosal Th1/Th2 response in Whipple’s disease. Gastroenterology 123:1468–1477
Moos V, Kunkel D, Marth T, Feurle GE, LaScola B, Ignatius R, Zeitz M, Schneider T (2006) Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple’s disease. J Immunol 177:2015–2022
Schinnerling K, Moos V, Geelhaar A, Allers K, Loddenkemper C, Friebel J, Conrad K, Kühl AA, Erben U, Schneider T (2011) Regulatory T cells in patients with Whipple’s disease. J Immunol 187:4061–4067
Blaschitz C, Raffatellu M (2010) Th17 cytokines and the gut mucosal barrier. J Clin Immunol 30:196–203
Peck A, Mellins ED (2010) Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 129:147–153
Savage ND, de Boer T, Walburg KV, Joosten SA, van Meijgaarden K, Geluk A, Ottenhoff TH (2008) Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFβ-1. J Immunol 181:2220–2226
Ollier WE (2004) Cytokine genes and disease susceptibility. Cytokine 28:174–178
Feurle GE, Moos V, Schinnerling K, Geelhaar A, Allers K, Biagi F, Bläker H, Moter A, Loddenkemper C, Jansen A, Schneider T (2010) The immune reconstitution inflammatory syndrome in Whipple disease: a cohort study. Ann Intern Med 153:710–717
Uboldi de Capei MU, Dametto E, Fasano ME, Rendine S, Curtoni ES (2003) Genotyping for cytokine polymorphisms: allele frequencies in the Italian population. Eur J Immunogenet 30:5–10
Gao L, Weck MN, Nieters A, Brenner H (2009) Association between a pro-inflammatory genetic profile and the risk of chronic atrophic gastritis among older adults from Germany. Eur J Cancer 45:428–434
Deriban G, Marth T (2006) Current concepts of immunopathogenesis, diagnosis and therapy in Whipple’s disease. Curr Med Chem 13:2921–2926
Mantel PY, Schmidt-Weber CB (2011) Transforming growth factor-beta: recent advances on its role in immune tolerance. Methods Mol Biol 677:303–338
Acknowledgements
We are grateful to Susan West for reading and correcting the manuscript.
This project was funded by the Fifth Framework Programme of the European Commission (ref. QLG1-CT-2002-01049).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Biagi, F., Badulli, C., Feurle, G.E. et al. Cytokine genetic profile in Whipple’s disease. Eur J Clin Microbiol Infect Dis 31, 3145–3150 (2012). https://doi.org/10.1007/s10096-012-1677-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-012-1677-8